PURPOSE: To report visual acuity and intraocular pressure outcomes among pa
tients who have undergone combined pars plana vitrectomy and placement of a
glaucoma drainage implant.
METHODS: The medical records of all patients who underwent combined pars pl
ana vitrectomy and placement of a glaucoma drainage implant at the Bascom P
almer Eye Institute by one of the authors between January 1, 1990, and Febr
uary 28, 1998, were reviewed. Forty patients (40 eyes) were identified, inc
luding 14 patients with neovascular glaucoma secondary to proliferative dia
betic retinopathy or central retinal vein occlusion, 15 patients with other
posterior segment disease, seven patients with secondary angle-closure gla
ucoma, and four patients with aphakia with ruptured anterior hyaloid face.
Main outcome measures included visual acuity and intraocular pressure at 1
year postoperatively.
RESULTS: At 1 year postoperatively, 31 (77.5%) of 40 patients had stable or
improved visual acuity; three eyes (7.5%) had a final visual acuity of no
light perception and three additional eyes (7.5%) were enucleated (because
of chronic pain in two eyes and endophthalmitis in one eye). Mean preoperat
ive intraocular pressure was 34 mm Hg and the median number of preoperative
antiglaucoma medications was two. At 1 year postoperatively, mean intraocu
lar pressure was 13 mm Hg and the median number of antiglaucoma medications
was zero. Twenty-two patients (55.0%) achieved an intraocular pressure gre
ater than 5 mm Hg and less than or equal to 21 mm Hg without antiglaucoma m
edication, and an additional seven patients (17.5%) achieved this level of
intraocular pressure control with medication. Only one patient (2.5%) under
went further glaucoma surgery for uncontrolled intraocular pressure.
CONCLUSIONS: Although combined pars plana vitrectomy and placement of a gla
ucoma drainage implant is often a successful management option in selected
patients with refractory glaucoma, visual outcome may be poor because of se
vere underlying ocular disease and postoperative complications. (C) 2000 by
Elsevier Science Inc. All rights reserved.